We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GVK BIO Enters into Drug Discovery Pact with Wyeth Pharmaceuticals
News

GVK BIO Enters into Drug Discovery Pact with Wyeth Pharmaceuticals

GVK BIO Enters into Drug Discovery Pact with Wyeth Pharmaceuticals
News

GVK BIO Enters into Drug Discovery Pact with Wyeth Pharmaceuticals

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GVK BIO Enters into Drug Discovery Pact with Wyeth Pharmaceuticals"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GVK BIO has announced that it has entered into a research agreement with Wyeth Pharmaceuticals, a division of Wyeth to discover drug candidates focused on pre-defined discovery targets. GVK BIO will utilize in-house capabilities in Discovery Chemistry, Informatics, Biology and ADME to advance this program.

GVK BIO will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance these compounds towards clinical studies. Under the agreement, GVK BIO will receive an initial payment and will be eligible for success-based milestone payments.

Mr. G V Sanjay Reddy, Managing Director, GVK Biosciences said “It is a momentous occasion for us. GVK BIO has had a successful partnership with Wyeth on various chemistry research activities dating to 2006. This research agreement expands our work together and builds on GVK BIO’s core strengths. This agreement further validates India’s capability to do innovative research along with leading pharmaceutical and biotech companies”.

Advertisement